Active Ingredient(s): Pegfilgrastim
FDA Approved: * January 31, 2002
Pharm Company: * AMGEN
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Neulasta Overview

Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the production of white blood cells (neutrophils).[3] Pegfilgrastim treatment can be used to stimulate bone marrow to produce more neutrophils to fight infection in patients undergoing chemotherapy.[4] Pegfilgrastim has a human half-life of 15 to 80 hours, much longer than the parent filgrastim (3–4 hours).&...

Read more Neulasta Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Neulasta Forums: RSS Feed


stimulate low white blood cells during chemotherapy ## I think you meant Neulasta, it contains the active ingredient Pegfilgrastim. The FDA warns that it may cause side effects, such as nausea, administration site irritation, headache, kidney issues, and spleen rupture. Has it been prescribed for you?


wondering what side affects others have had from neulasta? ## I don't have any personal experience with this medication, but I was able to gather some details on the side effects one might expect while taking Neulasta... Common, less serious side effects can include: muscle, joint, or bone pain; temporary hair loss; nausea, vomiting, constipation, loss of appetite; changes in your sense of taste; weakness, dizziness; headache; or sleep problems (insomnia). Other more serious side effects are: sudden or severe pain in your left upper stomach spreading up to your shoulder; rapid breathing or feeling short of breath; any sign of infection such as fever, chills, body aches, flu symptoms, diarrhea, skin rash, or redness or swelling of a skin wound; swelling in your hands, ankles, or feet...


Possible Dosages for this and Related Drugs:

  • Injection: 6mg/0.6ml
  • Syringe: 6mg/0.6ml, 6mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Neulasta: (3 results)

Sorted by National Drug Code
  • 54868-5229 Neulasta 6 mg/.6ml Subcutaneous Injection by Physicians Total Care, Inc.
  • 55513-190 Neulasta 6 mg/.6ml Subcutaneous Injection by Amgen Inc
  • 55513-192 Neulasta Subcutaneous Kit by Amgen Inc

Other drugs which contain Pegfilgrastim or a similar ingredient: (9 results)

Related Neulasta Topics:

wondering what side affects others have had from neulasta? ## I don't have any personal experience with this medicat... 1 reply

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA